BICO (HUREL CORP.)

Company Snapshot

Founded: 2016
Entity Type: Public
Employees: 711
Region: U.S.
Revenue: $184.1 Millions
Revenue Year: 2024
Headquarter: Goteborg, Sweden
Key Geographics: North America, Europe, Asia-Pacific, Other Countries
Corporate Address: Långfilsgatan 9 412 77 Göteborg Sweden Tel. +1-(888)-890-9889‬ www.bico.com

Company Overview

BICO specializes in advancing and commercializing bioprinting technologies, facilitating the printing of three-dimensional (3D) human organs and tissues for research purposes. Their product range includes bioprinters, drug screening tools, dispensing solutions, automated non-contact plate washers and liquid dispensers. Additionally, they offer pheromone, a platform for sorting and dispensing single large particles. BICO serves a diverse clientele, including research institutions and pharmaceutical, biopharmaceutical, automotive, and cosmetic companies.
Cellink and MatTek are the subsidiaries of BICO.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BICO (HUREL CORP.) In Reports

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

Organ-on-a-Chip: Global Markets

BCC Research Market Report for organ-on-a-chip market should reach $183.4 million by 2026 from $32.0 million in 2021 at a compound annual growth rate (CAGR) of 41.8%

In Vitro Toxicity Testing: Technologies and Global Markets

BCC Research Market Report for In Vitro Toxicity Testing market. global In Vitro Toxicity Testing market trends, with CAGRs through 2026.

Company's Business Segments

  • Bioprinting : This segment offers 3D-bioprinters, 3D printers, and bioink with a broad range of technologies for various demanding applications, resolutions (50 micrometers—200 nanometers), and volume/speed requirements. It also offers services focused on the rapid discovery and development of new drugs, including advanced tissue imaging and cell culture services.
  • Biosciences : This segment provides advanced lab instruments and software for connected intelligent workflows for analyzing data, with applications in cell culture, cell imaging, cell sorting, and sample preparation for various analyses, such as genomics.
  • Bioautomation : This segment provides scientific instruments and solutions for scalable diagnostics and consumables production that enable single-cell and other workflows.

Applications/End User Industries

  • Lab Automation
  • Life Science Solutions
  • Bioprinting
AI Sentiment